Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis B (HBeAg-negative)”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Large-scale testing (Phase 3)Study completedNCT00117676
What this trial is testing

Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 382
Large-scale testing (Phase 3)Study completedNCT01237496
What this trial is testing

Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 17
Not applicableStudy completedNCT02743182
What this trial is testing

HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients

Who this might be right for
Chronic Hepatitis B (HBeAg-negative)
José Antonio Carrion 119
Testing effectiveness (Phase 2)UnknownNCT04568265
What this trial is testing

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hep BHBV
Ascentage Pharma Group Inc. 122
Large-scale testing (Phase 3)Study completedNCT01697501
What this trial is testing

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 88
Testing effectiveness (Phase 2)Ended earlyNCT02604199
What this trial is testing

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 58
Post-approval studies (Phase 4)Active Not RecruitingNCT06743438
What this trial is testing

Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB

Who this might be right for
Hepatitis B, Chronic
Jiangsu Hansoh Pharmaceutical Co., Ltd. 640
Post-approval studies (Phase 4)Study completedNCT02594293
What this trial is testing

Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 180
Testing effectiveness (Phase 2)Study completedNCT05839639
What this trial is testing

Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors

Who this might be right for
Chronic Hepatitis B
Huahui Health 73
Post-approval studies (Phase 4)WithdrawnNCT01179594
What this trial is testing

48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche
Early research (Phase 1)Study completedNCT06744686
What this trial is testing

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

Who this might be right for
Chronic Hepatitis B
Suzhou HepaThera Biotech Co., Ltd. 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370207
What this trial is testing

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Who this might be right for
Hepatitis B, Chronic
AusperBio Therapeutics Inc. 84
Early research (Phase 1)WithdrawnNCT05867056
What this trial is testing

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Immunocore Ltd
Post-approval studies (Phase 4)UnknownNCT00917761
What this trial is testing

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
National Taiwan University Hospital 300
Large-scale testing (Phase 3)Ended earlyNCT00823342
What this trial is testing

ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

Who this might be right for
HBe Negative Chronic Hepatitis BHepatitis B Viral Infection
French National Agency for Research on AIDS and Viral Hepatitis 150
Post-approval studies (Phase 4)Study completedNCT00487747
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 18
Testing effectiveness (Phase 2)Study completedNCT02881008
What this trial is testing

Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hepatera Ltd. 48
Not applicableWithdrawnNCT01260610
What this trial is testing

Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Institute of Liver and Biliary Sciences, India
Large-scale testing (Phase 3)Study completedNCT00661076
What this trial is testing

ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 10
Post-approval studies (Phase 4)Study completedNCT03681132
What this trial is testing

The Norwegian Nucleoside Analogue Stop Study

Who this might be right for
Hepatitis B, Chronic
Oslo University Hospital 127
Load More Results